Violation Tracker Individual Record
Company:C.R. Bard Inc.
Date:May 13, 2013
Primary Offense:False Claims Act and related
C.R. Bard Inc. agreed to pay the United States $48.26 million to resolve claims that it knowingly caused false claims to be submitted to the Medicare program for brachytherapy seeds used to treat prostate cancer in violation of the False Claims Act.
Level of Government:federal
Action Type:agency action
Agency:Justice Department Civil Division
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:New Jersey
Ownership Structure of Parent:publicly traded
Major Industry of Parent:medical equipment and supplies
Specific Industry of Parent:medical supplies
Source of Data:
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.